Reuters logo
2 months ago
BRIEF-Intersect ENT says U.S. FDA has accepted NDA for its investigational Sinuva steroid releasing sinus implant
May 22, 2017 / 11:15 AM / 2 months ago

BRIEF-Intersect ENT says U.S. FDA has accepted NDA for its investigational Sinuva steroid releasing sinus implant

1 Min Read

May 22 (Reuters) - Intersect Ent Inc

* Intersect ENT Inc says U.S. FDA has accepted new drug application for company's investigational Sinuva™ steroid releasing sinus implant

* Intersect ENT Inc says U.S. FDA set a PDUFA target action date of January 7, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below